SEC Form 4/A · accession 0001209191-17-020162
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert Silverman
Officer — Senior VP, General Counsel
Period of report
Jan 20, 2016
Accepted (ET)
Mar 13, 2017 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1 | $1.13 | Jan 20, 2016 | M | 8,000 | D | — | Dec 11, 2017 | Common Stock | 8,000 | 11,469 | D |
Explanation of responses
- F1This option is fully vested.
- F2This Form 4/A is being filed to correct the Expiration Date in the reported transaction from 06/04/2017 to 12/11/2017 and to correct the Number of Derivative Securities Beneficially Owned Following the Reported Transaction from 11,497 to 11,469.